The reopening of the Mabanga Center: new hope for patients with sickle cell disease
October 2023 will mark a major turning point in the fight against sickle cell disease in the Democratic Republic of Congo. Indeed, the long-awaited reopening of the Mabanga Center is planned for this month, offering new hope to patients suffering from this genetic disease.
Located in the heart of the capital, Kinshasa, the Mabanga Center has undergone extensive renovation and modernization to provide state-of-the-art medical facilities meeting the highest health standards. Under the initiative of the Denise Nyakeru Tshisekedi Foundation, this mixed medicine and anemia facility will be equipped with new equipment and additional services such as ophthalmology and dentistry, thereby meeting the varied needs of the community.
The recent visit of the President of the Foundation, Denise Nyakeru Tshisekedi, to the Mabanga Center site ensured that the work is progressing according to the planned schedule. This initiative demonstrates the Foundation’s continued commitment to improving health care in the DRC.
Since its creation, the Denise Nyakeru Tshisekedi Foundation has played a vital role in raising awareness about sickle cell disease, highlighting the importance of early detection and electrophoresis. In addition, she provided support to structures treating patients with sickle cell anemia.
During the renovation period, patients from the Mabanga Center were temporarily transferred to the Yolo Medical Center, where they were able to benefit from continuous and attentive care. But the reopening of the Mabanga Center marks an expected return for these patients, who will be able to be cared for in a renovated environment conducive to their treatment.
Sickle cell disease is a genetic disease that primarily affects red blood cells and can lead to serious health complications. The reopening of the Mabanga Center is therefore a crucial step forward in the fight against this disease, offering patients more specialized medical care adapted to their needs.
The reopening of the Mabanga Center is also the result of valuable collaboration with key partners. Thanks to their support and contribution, patients suffering from sickle cell disease in the DRC will now have access to quality care and will be able to benefit from optimal medical support.
In conclusion, the imminent reopening of the Mabanga Center represents a significant step forward in the fight against sickle cell disease in the DRC. Thanks to the efforts of the Denise Nyakeru Tshisekedi Foundation and its partners, patients will be able to receive specialized care tailored to their needs, paving the way for a more promising future for those affected by this genetic disease.